Abbott: all 1,345 studies

Page 11 of 14. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart FailureTerminatedNCT00744341Phase 2
• Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention IndicationCompletedNCT00743522
• A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult SubjectsTerminatedNCT00743470Phase 1
• Assess the Oral Bioavailability of New ABT-263 FormulationsCompletedNCT00743028Phase 1
• Af Ablation In Brady-Tachy SyndromeTerminatedNCT00740272Not applicable
• A Trial of PDL192 in Subjects With Advanced Solid TumorsCompletedNCT00738764Phase 1
• RISE: A Clinical Evaluation of the StarClose™ Vascular Closure SystemCompletedNCT00736086
• A(f)MAZE-CABG StudyTerminatedNCT00735722Not applicable
• A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.TerminatedNCT00735085Phase 2
• XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in DeliveryCompletedNCT00731237
• An Observational, Prospective Evaluation of the Trifecta™ ValveCompletedNCT00727181Not applicable
• Multicenter International Trial Ring AnnulopLastyCompletedNCT00727012Not applicable
• A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.TerminatedNCT00726869Phase 1
• Evaluation of a Medical Food for Chronic WoundsCompletedNCT00711217Phase 3
• Nutritional Study in Preterm InfantsCompletedNCT00707837Phase 3
• Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic PancreatitisCompletedNCT00705978Phase 3
• Tolerance of Healthy Term Infants Fed Infant FormulasCompletedNCT00705562Phase 2
• A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.CompletedNCT00703755Phase 2
• A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
• Effect of Choline Fenofibrate (SLV348) on Macular EdemaCompletedNCT00683176Phase 2
• A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and EzetimibeCompletedNCT00681525Phase 1
• Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese HypertensivesCompletedNCT00679653Phase 3
• Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationCompletedNCT00677391Phase 3
• A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00666692Phase 1
• Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.CompletedNCT00665509Phase 3
• Atrial Fibrillation Management in Congestive Heart Failure With AblationCompletedNCT00652522Not applicable
• Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody AdalimumabApproved for marketingNCT00650390
• Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid ArthritisApproved for marketingNCT00650026
• Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid ArthritisCompletedNCT00649922Phase 4
• Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid ArthritisApproved for marketingNCT00649545
• Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00647920Phase 3
• A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00647491Phase 2/3
• Paricalcitol Injection Phase II TrialCompletedNCT00646932Phase 2
• Pediatric Switch Study for Children and Adolescent Patients With EpilepsyCompletedNCT00646711Phase 2
• Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic ArthritisCompletedNCT00646386Phase 2
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00646191Phase 2
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug TherapyCompletedNCT00646178Phase 3
• A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal DialysisCompletedNCT00646035Phase 3
• Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645905Phase 2
• Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645892Phase 2
• Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645814Phase 2
• Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese SubjectsTerminatedNCT00645255Phase 3
• Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis MediaCompletedNCT00645203Phase 2/3
• A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension MedicationsCompletedNCT00645125Phase 4
• A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis MediaCompletedNCT00645112Phase 4
• Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic BronchitisCompletedNCT00645086Phase 3
• Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial SinusitisCompletedNCT00645073Phase 4
• A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis MediaCompletedNCT00644943Phase 4
• Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension MedicationsCompletedNCT00644891Phase 4
• A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension MedicationsCompletedNCT00644774Phase 4
• Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial SinusitisCompletedNCT00644553Phase 3
• Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingCompletedNCT00642512Phase 3
• Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNCT00642499Phase 2
• EnSite Real-Time Cardiac Performance Measurements (RT CPM) StudyCompletedNCT00632450
• Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring StudyCompletedNCT00632372
• XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm StudyCompletedNCT00631228
• Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisTerminatedNCT00630279Phase 2
• Creon in HIV Patients With SteatorrheaTerminatedNCT00623025Phase 3
• Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac ArteryWithdrawnNCT00613418Not applicable
• Artificial Tears Study in Mild to Moderate Dry Eye PatientsCompletedNCT00607776Phase 2
• Gen2 Isthmus-Dependent Atrial Flutter Ablation StudyTerminatedNCT00606463Not applicable
• Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 YearsCompletedNCT00599443Phase 1
• Effect of Omacor on Triglycerides in HIV Infected SubjectsTerminatedNCT00598910Phase 4
• The TRIMAXX Coronary Stent TrialCompletedNCT00596661Phase 1
• Emergency/Compassionate Use - Muscular VSD OccluderApproved for marketingNCT00590382
• Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian ChildrenCompletedNCT00585481
• Emergency/Compassionate Use PFO OccluderApproved for marketingNCT00584064
• Emergency/Compassionate Use - AMPLATZER Duct OccluderNo longer availableNCT00583583
• Emergency/Compassionate Use - Membranous VSD OccluderNo longer availableNCT00583505
• PFO ACCESS RegistryNo longer availableNCT00583401
• Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDERCompletedNCT00578708Phase 1
• Placement of CS/LV Pacing Leads With EnSite NavX GuidanceWithdrawnNCT00577187Early Phase 1
• Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal FunctionTerminatedNCT00568009
• Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's DiseaseTerminatedNCT00562887Phase 2
• Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic VaccineTerminatedNCT00562237Phase 1
• PAtient NOtifier Feature for Reduction of AnxietyCompletedNCT00559559Not applicable
• Dynamic Substrate Mapping (DSM) for Ischemic VTTerminatedNCT00558857Phase 1
• Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00555204Phase 2
• A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)TerminatedNCT00554385Phase 2
• Mitral Adjustable Annuloplasty Ring Feasibility and Safety StudyCompletedNCT00554151Not applicable
• Deep Brain Stimulation to Treat Symptoms of Parkinson's DiseaseCompletedNCT00552474Not applicable
• AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AFTerminatedNCT00547794
• Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesCompletedNCT00544206Phase 2
• Tolerance of Healthy, Term Infants to Infant FormulasCompletedNCT00543673Phase 2/3
• Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy PeopleCompletedNCT00543647Phase 1
• An Intervention Program to Control DiabetesCompletedNCT00543621Phase 4
• BMS-646256 in Obese and Overweight Type 2 DiabeticsWithdrawnNCT00541567Phase 2/3
• Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional FormulasCompletedNCT00540488Phase 3
• Creon After Pancreatic SurgeryCompletedNCT00535756Phase 4
• A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With HypertensionWithdrawnNCT00528827Phase 2
• Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00520065Phase 2
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTerminatedNCT00516841Phase 2
• Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field SensingCompletedNCT00512915Phase 4
• A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory AsthmaWithdrawnNCT00512863Phase 2
• PRIMA PFO Migraine TrialTerminatedNCT00505570Phase 2
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative ColitisWithdrawnNCT00502294Phase 3
• Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring StudyCompletedNCT00500838Not applicable
• Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 DiabetesCompletedNCT00499148Phase 2/3
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3

← Abbott overview and focus areas